The dose-dependent neuroprotective effect of norepinephrine in improving memory retrieval in an experimental model of multiple sclerosis, experimental autoimmune encephalomyelitis

• Published in: Brain research bulletin Vol. 209; p. 110907
• Main Authors: Taherian, Narjes, Vaezi, Gholamhassan, Neamati, Ali, Hojjati, Vida, Ghorbani-Taherdehi, Faezeh, Sahebkar, Amirhossein, Gorji-Valokola, Mahmoud
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2024; Elsevier
• Subjects: Apoptosis; Hippocampus; Memory; Multiple sclerosis; Norepinephrine; Multiple sclerosis; Norepinephrine; Memory; Hippocampus; Apoptosis
• ISSN: 0361-9230; 1873-2747
• DOI: 10.1016/j.brainresbull.2024.110907

Multiple sclerosis (MS) is considered an immune-mediated inflammatory disorder that causes cognitive impairments by damaging the hippocampal tissue. Conversely, norepinephrine (NEP) has anti-inflammatory and re-myelinating properties, which improve cognitive impairments. The aim of this study was to assess the neuroprotective effects of NEP on learning and memory disorders in an experimental animal model of MS. Two guide cannulas were bilaterally implanted in the rat hippocampal CA1 regions. After recovery, the animals received 3 μl of 0.01% ethidium bromide (EtB) in each of both hippocampal regions. After three days, the rats were randomly divided into 6 groups (8 rats/group), including control, sham 1, sham 2, and three groups of NEP 0.25, 0.5, and 1 mg/kg by intrahippocampal injection. Behavioral tests (e.g. shuttle box test and open-field test) were then performed. Finally, ROS, MDA, GSH, TNF-α, IL-6, and IL-1β concentrations in the left CA1 area, as well as using western-blot analysis, p-p38, p-JNK, p-AKT, p-ERK1/2, p-NMDA, p-AMPA, p-CREB, and BDNF proteins in the right CA1 region evaluated. The EtB injection increased ROS, MDA, TNF-α, IL-6, and IL-1β levels, as well as p-JNK and p-P38, except all other proteins, while decreasing GSH content, as well as step-through latency and locomotor activity in sham groups compared to the control group. Conversely, NEP (0.5 and 1 mg/kg, particularly at the dose of 1 mg/kg) counterbalanced all the alterations mentioned above in comparison to the sham groups. The EtB induced learning and memory impairment; however, NEP dose-dependently restored these impairments to normal levels.
[Display omitted]
•Ethidium bromide induces brain injury, especially multiple sclerosis.•Multiple sclerosis effects on hippocampus-dependent learning and memory.•Norepinephrine has the anti-inflammatory which are potent protective compounds against brain diseases.•In this study we showed that ethidium bromide resulted in significant deficit in passive avoidance learning, locomotor activity, and other factors, including ROS, MDA, GSH, TNF-α, IL-6, IL-1β, p-p38, p-JNK, p-AKT, p-ERK1/2, p-NMDA, p-AMPA, p-CREB, and BDNF while norepinephrine therapy was markedly improved these side effects in the mice hippocampus of multiple sclerosis.